---
document_datetime: 2023-09-21 20:38:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/synagis-epar-all-authorised-presentations_en.pdf
document_name: synagis-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8101078
conversion_datetime: 2025-12-17 09:15:00.953877
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | Invented name   | Strength     | Pharmaceutical Form    | Route of Administration   | Immediate Packaging   | Content (concentratio n)   | Pack size   |
|------------------|-----------------|--------------|------------------------|---------------------------|-----------------------|----------------------------|-------------|
| EU/1/99/117/003  | Synagis         | 50 mg/0.5 ml | Solution for injection | Intramuscular use         | vial (glass)          | 0.5 ml                     | 1 vial      |
| EU/1/99/117/004  | Synagis         | 100 mg/1 ml  | Solution for injection | Intramuscular use         | vial (glass)          | 1.0 ml                     | 1 vial      |